Re. Re.: “Immunothrombotic dysregulation in Chagas disease and COVID19: a comparative study of anticoagulation”

0Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Re. Re.: “Immunothrombotic dysregulation in Chagas disease (CD) and COVID-19: a comparative study of anticoagulation”: In the commentary on our paper, Hasslocher-Moreno made the point that indeterminate and digestive forms are not related to thromboembolic events, only thrombogenic alterations occur in CD with cardiopathy, however there is indirect evidence related to thombotic alterations, such as cerebral thrombosis. Our assertion is based on previous data discussed in this letter.

Author supplied keywords

Cite

CITATION STYLE

APA

Pérez-Campos Mayoral, L., Hernández-Huerta, M. T., Pérez-Campos Mayoral, E., Matias Cervantes, C. A., & Pérez-Campos, E. (2023, February 1). Re. Re.: “Immunothrombotic dysregulation in Chagas disease and COVID19: a comparative study of anticoagulation.” Molecular and Cellular Biochemistry. Springer. https://doi.org/10.1007/s11010-022-04511-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free